ATE80913T1 - Hybride expressionsvektoren, deren herstellung und verwendungen. - Google Patents
Hybride expressionsvektoren, deren herstellung und verwendungen.Info
- Publication number
- ATE80913T1 ATE80913T1 AT87302093T AT87302093T ATE80913T1 AT E80913 T1 ATE80913 T1 AT E80913T1 AT 87302093 T AT87302093 T AT 87302093T AT 87302093 T AT87302093 T AT 87302093T AT E80913 T1 ATE80913 T1 AT E80913T1
- Authority
- AT
- Austria
- Prior art keywords
- site
- production
- expression vectors
- ecori
- hybrid expression
- Prior art date
Links
- 239000013604 expression vector Substances 0.000 title 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 125000002707 L-tryptophyl group Chemical group [H]C1=C([H])C([H])=C2C(C([C@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 abstract 1
- 239000013613 expression plasmid Substances 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Secondary Cells (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83877286A | 1986-03-12 | 1986-03-12 | |
| EP87302093A EP0237338B1 (de) | 1986-03-12 | 1987-03-11 | Hybride Expressionsvektoren, deren Herstellung und Verwendungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE80913T1 true ATE80913T1 (de) | 1992-10-15 |
Family
ID=25278007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87302093T ATE80913T1 (de) | 1986-03-12 | 1987-03-11 | Hybride expressionsvektoren, deren herstellung und verwendungen. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0237338B1 (de) |
| JP (1) | JPS62220192A (de) |
| AT (1) | ATE80913T1 (de) |
| DE (1) | DE3781819T2 (de) |
| ES (1) | ES2035043T3 (de) |
| GR (1) | GR3006649T3 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2587305B2 (ja) * | 1990-03-07 | 1997-03-05 | チッソ株式会社 | リパーゼ発現用組換え体プラスミド及びリパーゼの製造法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL65775A (en) * | 1981-05-18 | 1985-05-31 | Genentech Inc | Microbial hybrid promotors and plasmids and e.coli comprising them |
| EP0108387B1 (de) * | 1982-11-04 | 1990-05-16 | F. Hoffmann-La Roche Ag | Hestellung von rekombinanten wachstumsauslösenden Faktoren |
| JPS60160887A (ja) * | 1984-02-02 | 1985-08-22 | Green Cross Corp:The | ベクタ− |
| DE3526995A1 (de) * | 1985-07-27 | 1987-02-05 | Hoechst Ag | Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung |
-
1987
- 1987-03-11 AT AT87302093T patent/ATE80913T1/de not_active IP Right Cessation
- 1987-03-11 JP JP62054304A patent/JPS62220192A/ja active Pending
- 1987-03-11 ES ES198787302093T patent/ES2035043T3/es not_active Expired - Lifetime
- 1987-03-11 DE DE8787302093T patent/DE3781819T2/de not_active Expired - Fee Related
- 1987-03-11 EP EP87302093A patent/EP0237338B1/de not_active Expired - Lifetime
-
1992
- 1992-12-23 GR GR920403102T patent/GR3006649T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2035043T3 (es) | 1993-04-16 |
| DE3781819D1 (de) | 1992-10-29 |
| EP0237338A2 (de) | 1987-09-16 |
| EP0237338B1 (de) | 1992-09-23 |
| EP0237338A3 (en) | 1988-08-17 |
| JPS62220192A (ja) | 1987-09-28 |
| DE3781819T2 (de) | 1993-01-07 |
| GR3006649T3 (de) | 1993-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5151423B1 (en) | Heterocyclic n-oxide derivatives of substituted benzo(5,6)cycloheptapyridines, compositions and methods of use | |
| EG18579A (en) | Process for preparing of anti-inflammatory agents | |
| EP0053448A3 (en) | Pre-shampoo type hair treatment composition | |
| ATE177473T1 (de) | Herstellung von rekombinanten, menschlichem lactoferrin | |
| GR3007280T3 (de) | ||
| ES2111579T3 (es) | Preparaciones de factor viii estabilizadas. | |
| AU2452288A (en) | Nucleoside derivatives useful in treating retroviral infections | |
| ES2054701T3 (es) | Clonacion y expresion de dna conteniendo el codigo de la toxina bordetella pertussis. | |
| HUT66437A (en) | A composition used as a therapeutic agent against chronic viral hepatic diseases | |
| HUT45960A (en) | Process for producing 2,4,5-trisubstituted derivatives of phenol of antiflogistic activity | |
| NO864495L (no) | Hybrid-plasmider, ekspresjonsvektorer, nukleotidsekvenser, samt fremgangsmaate for fremstilling av human-lysozym. | |
| FI834700A0 (fi) | Dna-sekvenser, deras framstaellning, dessa sekvenser innehaollande plasmider och deras anvaendning syntes av eukaryotiska genprodukter i prokaryoten | |
| IT8519626A0 (it) | Ottenimento di perfluoropolieteri a peso molecolare controllato dal prodotto di ossidazione fotochimica del c2f4 | |
| ATE80913T1 (de) | Hybride expressionsvektoren, deren herstellung und verwendungen. | |
| YU237990A (sh) | Morfolinil derivati doksorubicina i postupak za njihovo dobijanje | |
| ES8305323A1 (es) | "procedimiento para la preparacion de un disulfuro de tiuram sustituido con radicales hidrocarbonados alifaticos, aralifaticos y o cicloalifaticos". | |
| DE68927055D1 (de) | 2',5'-oligoadenylat-derivate zur verwendung als heilmittel | |
| SE8900875D0 (sv) | Osteoporosis treatment | |
| FR2666588B1 (fr) | Sequence nucleotidique regulatrice de l'initiation de transcription. | |
| DK192482A (da) | Plasmid p sg 2 og fremgangsmaade til dets fremstilling | |
| EP0034647A3 (en) | 4-aryloxy- and 4-arylthio-3-phenylpiperidine derivatives, a process for the preparation of such compounds and their use as medicaments | |
| LV10870A (lv) | Jauni fosfolipidu atvasinajumi | |
| FI912269A0 (fi) | 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa. | |
| AU6668490A (en) | Glutaric acid derivatives and preparations thereof | |
| EP0252305A3 (de) | Verwendung von Avaron und Avarol und deren Derivaten zur Herstellung einer pharmazeutischen Zusammensetzung zur Bekämpfung von T-Zellen-Leukämie/Lymphom bei Erwachsenen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner | ||
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |